Drug-Induced Anaphylaxis in Latin American Countries

Journal of Allergy and Clinical Immunology: In Practice

Volumn 3, Issue 5, 2015, Pages 780-788

  Jares, Edgardo José ^a   Baena Cagnani, Carlos E ^b   Sánchez Borges, Mario ^c   Ensina, Luis Felipe C ^d   Arias Cruz, Alfredo ^e   Gómez, Maximiliano ^f   Cuello, Mabel Noemi ^g   Morfin Maciel, Blanca María ^h   De Falco, Alicia ⁱ   Barayazarra, Susana ^j   Bernstein, Jonathan A ^k   Serrano, Carlos ^l   Monsell, Silvana ^a   Schuhl, Juan ^m   Cardona Villa, Ricardo ⁿ   Zanacchi, Viviana Andrea ^o   Cherrez, Ivan ^o   Salvatierra, Adolfo ^o   Diez, Susana ^o   Toche, Paola ^o   Díaz, Sandra González ^o   Felix, Mara Morelo Rocha ^o   Zuloaga, Luis Fernando Ramírez ^o   Vinuesa, Miguel ^o   Bissinger, Ingrid ^o   Zuluaga, Luis Fernando Ramírez ^o   Weisz, Adriana ^o   Mendez, Ada Castillo ^o   Mercovich, Gregorio ^o   Piza, Cristina F S T ^o   Castillo, Antonio J ^o   Alcaraz, Perla ^o   Herrera, Eugenia ^o   Malaman, Maria Fernanda ^o   Mimessi, Galie ^o   more..

^a CMP SA   (Argentina)

^b UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^c Centro Medico Docente La Trinidad   (Venezuela)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^f Hospital San Bernardo   (Argentina)

^g Allergy and Immunology Department   (Argentina)

^h Hospital Angeles Mocel   (Mexico)

ⁱ UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^j Hospital Zonal General Agudos San Roque   (Argentina)

^k UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^l FUNDACIÓN VALLE DEL LILI   (Colombia)

^m British Hospital Montevideo   (Uruguay)

ⁿ UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^o NONE

more..

Author keywords

Anaphylaxis; Drug allergy; Epidemiology; Epinephrine; Latin America

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ATRACURIUM BESILATE; BETA LACTAM ANTIBIOTIC; BUPIVACAINE; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DICLOFENAC; DIPYRONE; IBUPROFEN; KETOPROFEN; LEVOFLOXACIN; LIDOCAINE; LINCOMYCIN; MELOXICAM; NALIDIXIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; PENICILLIN V; PROPOFOL; ROCURONIUM; SUXAMETHONIUM; UNINDEXED DRUG; VECURONIUM; ALLERGEN; BETA LACTAM;

ADULT; ANAPHYLAXIS; ARTICLE; ATOPY; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG INDUCED ALLERGIC REACTION; DRUG INDUCED ANAPHYLAXIS; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SOUTH AND CENTRAL AMERICA; AGE; AGED; CHILD; COMPLICATION; IMMUNOLOGY; PRACTICE GUIDELINE; PREVALENCE; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; ALLERGENS; ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-LACTAMS; CHILD; CROSS-SECTIONAL STUDIES; DRUG HYPERSENSITIVITY; EPINEPHRINE; FEMALE; HUMANS; LATIN AMERICA; MALE; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; SEX FACTORS;

EID: 84941260311     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2015.05.012     Document Type: Article

References (59)

1. Simons E., Ardusso L., Bilo M., Cardona V., Ebisawa M., El-Gamal Y.M., et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014, 7:12.
2. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson N.F., Bock S.A., Branum A., et al. Second Symposium on the Definition and Management of Anaphylaxis: Summary Report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. Ann Emerg Med 2006, 47:373-380.
3. Moneret-Vautrin D.A., Morisset M., Flabbee J., Beaudouin E., Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005, 60:443-451.
4. Techapornroong M., Akrawinthawong K., Cheungpasitporn W., Ruxrungtham K. Anaphylaxis: a ten years inpatient retrospective study. Asian Pac J Allergy Immunol 2010, 28:262-269.
5. Decker W.W., Campbell R.L., Manivannan V., Luke A., St Sauver J.L., Weaver A., et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008, 122:1161-1165.
6. Poulos L.M., Waters A.M., Correl P.K., Loblay R.H., Marks G.B. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol 2007, 120:878-884.
7. Gupta R., Sheikh A., Strachan D.P., Anderson H.R. Time trends in allergic disorders in the UK. Thorax 2007, 62:91-96.
8. Mulla Z., Lin R., Simon M. Perspectives on anaphylaxis epidemiology in the United States with new data and analyses. Curr Allergy Asthma Rep 2011, 11:37-44.
9. van der Klauw M.M., Stricker B.H., Herings R.M., Cost W.S., Valkenburg H.A., Wilson J.H. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993, 35:400-408.
10. Brown A.F., McKinnon D., Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001, 108:861-866.
11. Gelincik A., Demirturk M., Yilmaz E., Ertek B., Erdogdu D., Çolakoğlu B., et al. Anaphylaxis in a tertiary adult allergy clinic: a retrospective review of 516 patients. Ann Allergy Asthma Immunol 2013, 110:96-100.
12. González-Pérez A., Aponte Z., Vidaurre C.F., Rodríguez L.A. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010, 125:1098-1104.
13. Sheikh A., Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000, 320:1441.
14. Low I., Stables S. Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005. Pathology 2006, 38:328-332.
15. Liew W.K., Williamson E., Tang M.L. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009, 123:434-442.
16. Aun M.V., Blanca M., Garro L.S., Ribeiro M.R., Kalil J., Motta A.A., et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract 2014, 2:414-420.
17. Sole D., Ivancevich J.C., Borges M.S., Coelho M., Rosario N., Ardusso L., et al. Latin American Anaphylaxis Working. Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA). Clinics (Sao Paulo) 2011, 66:943-947.
18. Mertes P., Alla F., Tréchot P., Auroy Y., Jougla E. Groupe d'Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011, 128:366-373.
19. Demoly P., Kropf R., Bircher A., Pichler W.J. Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity. Allergy 1999, 54:999-1003.
20. Jares E.J., Sánchez-Borges M., Cardona-Villa R., Ensina L.F., Arias-Cruz A., Gómez M., et al. Multinational experience with hypersensitivity drug reactions in Latin America. Ann Allergy Asthma Immunol 2014, 113:282-289. Latin America Drug Allergy Interest Group.
21. Simons F.E.R., Ardusso L.R.F., Bilo M.B., El-Gamal Y.M., Ledford D.K., Ring J., et al. World Allergy Organization anaphylaxis guidelines: a summary. J Allergy Clin Immunol 2011, 127:587-593. World Allergy Organization.
22. Simons F.E.R., Ardusso L.R.F., Bilo M.B., Dimov V., Ebisawa M., El-Gamal Y.M., et al. 2012 Update: World Allergy Organization (WAO) guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012, 12:389-399. World Allergy Organization.
23. Simons F.E., Ardusso L.R., Dimov V., Ebisawa M., El-Gamal Y.M., Lockey R.F., et al. World Allergy Organization anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013, 162:193-204. World Allergy Organization.
24. The Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. 2010. Available from: Accessed January 2, 2014. http://who-umc.org/Graphics/24734.pdf.
25. Ministerio de Salud, Secretaría de Políticas, Regulación e Institutos, ANMAT. Guía de buenas prácticas de farmacovigilancia. 2009. Available from: Accessed January 2, 2014. http://www.anmat.gov.ar/farmacovigilancia/docs/Guia_BPF.pdf.
26. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index; 2014. Available from: Accessed January 2, 2014. http://www.whocc.no/atc_ddd_index/.
27. Dean AG, Sullivan KM, Soe MM. OpenEpi: open source epidemiologic statistics for public health, version 2.3, updated May 20, 2009. Available from: Updated April 6, 2013. Accessed February 12, 2014. http://www.OpenEpi.com.
28. Silva R., Gomes E., Cunha L., Falcão H. Anaphylaxis in children: a nine years retrospective study (2001-2009). Allergol Immunopathol (Madr) 2012, 40:31-36.
29. Thong B.Y., Tan T.C. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol 2011, 71:684-700.
30. Faria E., Rodrigues-Cernadas J., Gaspar A., Botelho C., Castro E., Lopes A., et al. Drug-induced anaphylaxis survey in Portuguese Allergy Departments. J Investig Allergol Clin Immunol 2014, 24:40-48. Portuguese Society of Allergology and Clinical Immunology; Drug Allergy Interest Group.
31. Greenberger P.A., Rotskoff B.D., Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007, 98:252-257.
32. Simons F.E. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol 2009, 124:625-636.
33. Banerji A., Rudders S., Clark S., Wenhui Wei W., Long A., Camargo C. Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up. J Allergy Clin Immunol Pract 2014, 2:46-51.
34. Mirakian R., Ewan P.W., Durham S.R., Youlten L.J., Dugué P., Friedmann P.S., et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 2009, 39:43-61.
35. Demoly P., Hillaire-Buys D. Classification and epidemiology of hypersensitivity drug reactions. Immunol Allergy Clin North Am 2004, 24:34556.
36. Park H., Kim S. Factors associated with shock in anaphylaxis. Am J Emerg Med 2012, 30:1674-1678.
37. TenBrook J.A., Wolf M.P., Hoffman S.N., Rosenwasser L.J., Konstam M.A., Salem D.N., et al. Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004, 113:977-982.
38. Triggiani M., Patella V., Staiano R.I., Granata F., Marone G. Allergy and the cardiovascular system. Clin Exp Immunol 2008, 153(Suppl):7-11.
39. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol 2003, 3:313-318.
40. Mueller U.R. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007, 7:337-341.
41. Sánchez-Borges M. Etiology and clinical picture of anaphylaxis in ambulatory patients from Caracas, Venezuela. J Investig Allergol Clin Immunol 2010, 20:623-624.
42. Çelik G.E., Karakaya G., Öztürk A., Gelincik A., Abadoğlu O., Sin A., et al. Drug allergy in tertiary care in Turkey: results of a national survey. The ADAPT study: adult drug allergy perception in Turkey. Allergol Immunopathol (Madr) 2014, 42:573-579.
43. Messaad D., Sahla H., Benahmed S., Godard P., Bousquet J., Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004, 140:1001-1006.
44. Doña I., Blanca-López N., Torres M.J., Garcia-Campos J., Garcia-Nunez I., Gómez F., et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 2012, 22:363-371.
45. Cianferoni A., Novembre E., Mugnaini L., Lombardi E., Bernardini R., Pucci N., et al. Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996). Ann Allergy Asthma Immunol 2001, 87:27-32.
46. Ribeiro-Vaz I., Marques J., Demoly P., Polónia J., Gomes E.R. Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority. Eur J Clin Pharmacol 2013, 69:673-681.
47. Renaudin J.-M., Beaudouin E., Ponvert C., Demoly P., Moneret-Vautrin D.A. Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy 2013, 68:929-937.
48. Kowalski M.L., Asero R., Bavbek S., Blanca M., Blanca-Lopez N., Bochenek G., et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013, 68:1219-1232.
49. Quiralte J., Blanco C., Delgado J., Ortega N., Alcántara M., Castillo R., et al. Challenge based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J Investig Allergol Clin Immunol 2007, 17:182-188.
50. Sánchez-Borges M., Caballero-Fonseca F., Capriles-Hulett A. Nonsteroidal antiinflammatory drug-induced anaphylaxis. Anaphylaxis. Principles and Practice 2013, 163-177. Nova Science Publishers, New York. T. Krishna (Ed.).
51. Silva C.H., Giugliani E.R.J. Consumption of medicines among adolescent students: a concern. J Pediatr (Rio J) 2004, 80:326-332.
52. Sánchez-Borges M., Capriles-Hulett A., Caballero-Fonseca F. Risk of skin reactions when using ibuprofen-based medicines. Exp Opin Drug Saf 2005, 4:837-848.
53. Sala-Cunill A., Cardona V., Labrador-Horrillo M., Luengo O., Esteso O., Garriga T., et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol 2013, 160:192-199.
54. Srivastava S., Huissoon A.P., Barrett V., Hackett S., Dorrian S., Cooke M., et al. Systemic reactions and anaphylaxis with an acute serum tryptase =14 μg/L: retrospective characterisation of aetiology, severity and adherence to National Institute of Health and Care Excellence (NICE) guidelines for serial tryptase measurements and specialist referral. J Clin Pathol 2014, 67:614-619.
55. Campbell R.L., Li J.T., Nicklas R.A., Sadosty A.T. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol 2014, 113:599-608.
56. Dworzynski K., Ardern-Jones M., Nasser S. Guideline Development Group (GDG). Diagnosis and management of drug allergy in adults, children and young people: summary of NICE guidance. BMJ 2014, 349. g4852.
57. Sclar D.A., Lieberman P.L. Anaphylaxis: underdiagnosed, underreported, and undertreated. Am J Med 2014, 127(Suppl):S1-S5.
58. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction?. Curr Opin Allergy Clin Immunol 2004, 4:285-290.
59. Droste J., Narayan N. Anaphylaxis: lack of hospital doctors' knowledge of adrenaline (epinephrine) administration in adults could endanger patients' safety. Eur Ann Allergy Clin Immunol 2012, 44:122-127.